A compound developed by Johns Hopkins scientists that blocks glutamine metabolism can slow tumor progress, alter the tumor microenvironment and endorse the creation of sturdy and highly Lively anti-tumor T cells. “By targeting glutamine metabolism, we ended up not only ready to inhibit tumor development and change the tumor microenvironment, https://philipx614hez4.blogscribble.com/profile